Parents Fight for Newborn Disease Test After Son's Death

Parents of a seven-year-old boy who succumbed to a rare degenerative disease are heading to Westminster to urge for newborn testing. Teddy Johnson, diagnosed with Metachromatic Leukodystrophy (MLD) at 18 months old, passed away on April 16. His parents emphasized that by the time of diagnosis, it was too late for the available treatment, which is only effective if administered before symptoms manifest.

MLD, a condition affecting about one in 40,000 births, leads to a progressive loss of physical and mental functions. Despite Teddy meeting all developmental milestones initially, a noticeable limp at 17 months old signaled the onset of the disease. His parents recount their devastation upon receiving the diagnosis and the subsequent loss of his abilities.

The UK National Screening Committee recently advised against adding MLD to the routine newborn screening. They cited uncertainties regarding the accuracy of screening tests and the long-term health benefits of early intervention. This decision has drawn criticism, with researchers noting that a potentially curative gene therapy approved in the UK in 2022 has only been administered to a fraction of diagnosed children.

Teddy's parents are now campaigning to raise awareness among health leaders, asserting that his death could have been prevented. They aim to ensure other parents have the opportunity to save their children from this preventable tragedy. Their advocacy highlights the urgent need to re-examine the inclusion of MLD in newborn screening programs.